SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-239048
Filing Date
2020-09-03
Accepted
2020-09-03 16:10:59
Documents
2
Period of Report
2020-09-03
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d40621d8k.htm 8-K 17358
2 EX-99.1 d40621dex991.htm EX-99.1 58484
  Complete submission text file 0001193125-20-239048.txt   77062
Mailing Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210
Business Address 321 SUMMER STREET SUITE 400 BOSTON MA 02210 857-330-4340
Inozyme Pharma, Inc. (Filer) CIK: 0001693011 (see all company filings)

IRS No.: 475129768 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39397 | Film No.: 201159377
SIC: 2834 Pharmaceutical Preparations